Opens in a new tab

Dr. Chen Yunbin

Chinese name: 陈运彬
Chief Physician (Professional Technical Level II), Professor, Doctoral Supervisor, Chief Pediatric Expert . Neonatology
Dr. Chen Yunbin is Chief Pediatric Expert and former Vice President of Guangdong Women and Children Hospital, a professor and doctoral supervisor. A leading neonatologist, he chairs the Guangdong Perinatal Medicine Society and specializes in neonatal intensive care and the rescue of extremely low birth weight and critically ill newborns.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+ years
Neonatal and pediatric clinical practice
3+ papers
Peer-reviewed publications on newborn care
top national clinical grade
Technical Level II chief physician

  • The Physician

About Dr. Chen Yunbin

Dr. Chen Yunbin is Chief Pediatric Expert and former Vice President of Guangdong Women and Children Hospital, a professor, doctoral supervisor and Technical Level II chief physician. He chairs the Guangdong Medical Association Perinatal Medicine Branch and is an expert in neonatal intensive care, the rescue of extremely low birth weight infants and the management of respiratory and digestive disorders in children. He leads the hospital's pediatric master clinic program and has contributed to neonatal neurodevelopmental assessment. His clinical research on preterm infant respiratory support and late-onset sepsis has been published in international journals.
1、Chief Pediatric Expert and former Vice President of Guangdong Women and Children Hospital
2、Chair of the Guangdong Medical Association Perinatal Medicine Branch
3、Professor, doctoral supervisor and Technical Level II chief physician
4、Expert in the rescue of very low birth weight and critically ill newborns
5、Winner of the First Guangdong Physician Award (2018) and nominee for the Bethune-style Good Doctor Award (2017)
6、Leader of the hospital’s pediatric master clinic program

Dr. Chen Yunbin ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Neonatal intensive care

As a leading neonatologist, he manages critically ill newborns with respiratory failure, severe infection, prematurity and birth asphyxia, directing emergency resuscitation, ventilator support and intensive monitoring that stabilize fragile infants and significantly improve survival during the first days and weeks of life.

Extremely low birth weight infants

He specializes in the comprehensive care of extremely low birth weight preterm infants, coordinating temperature control, nutrition, infection prevention and developmental support to reduce complications such as chronic lung disease and promote healthy growth and neurodevelopment and reduce readmission throughout their hospital stay.

Neonatal neurodevelopmental assessment

He evaluates the neurological and intellectual development of newborns and high-risk infants, identifying early signs of developmental delay and guiding timely rehabilitation and intervention that help children reach their developmental milestones and achieve their full potential through coordinated follow-up care.

More: neonatal respiratory distress——ventilator and nasal cannula support; neonatal jaundice——phototherapy management; pediatric respiratory diseases——asthma and pneumonia care; pediatric digestive disorders——feeding and growth support

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Rescue of Respiratory Diseases in Quintuplet Extremely Low Birth Weight Infants
A clinical report from the Guangdong Women and Children Hospital neonatal team describing the rescue of naturally conceived quintuplet extremely low birth weight infants admitted to the NICU. With prenatal, intrapartum and postnatal monitoring, early surfactant therapy, careful ventilator use, temperature control and infection prevention, four of the five infants survived and developed normally by one year of age.
2. Diagnosis and Treatment of Bronchopulmonary Dysplasia: A 21-Case Analysis
A retrospective analysis of 255 newborns treated with mechanical ventilation between 1993 and 1998 at the Guangdong Women and Children Hospital, in which 21 infants developed bronchopulmonary dysplasia. The study emphasises early recognition of risk factors, adequate nutrition, short low-dose dexamethasone, aminophylline support, and strong treatment of underlying disease and complications to prevent and manage bronchopulmonary dysplasia in preterm infants.
3. Bronchopulmonary Dysplasia in Ventilated Newborns: A 12-Case Clinical Analysis
A clinical analysis of bronchopulmonary dysplasia among ventilated newborns at the Guangdong Women and Children Hospital, reviewing 202 neonates on respiratory support. It reports the incidence of bronchopulmonary dysplasia in preterm infants with hyaline membrane disease and summarises prevention and treatment experience, helping clinicians recognise oxygen and ventilator-related lung injury and improve outcomes for premature infants.
4. Intravenous Immunoglobulin for Ventilator-Associated Pneumonia in Extremely Low Birth Weight Infants
A randomised controlled study from the Guangdong Women and Children Hospital neonatal department evaluating intravenous immunoglobulin in 78 extremely low birth weight infants with ventilator-associated pneumonia. Thirty-four infants received immunoglobulin 400 mg/kg daily for three days; cure rate reached 70.6% versus 59.1% in controls, suggesting immunoglobulin reduces mortality and complications in this fragile group.
5. Colostrum Microbiota After Maternal Antibiotic Exposure: A 16S rRNA Sequencing Study
A study at the Guangdong Women and Children Hospital comparing colostrum from twenty women treated with antibiotics immediately after delivery and ten controls. Using 16S rRNA gene sequencing, researchers found lower microbial diversity and altered milk community structure after antibiotic exposure, providing evidence that supports careful antibiotic use and breastfeeding support for mothers and their newborns.
6. Bifidobacterium adolescentis Protects Against Necrotizing Enterocolitis in Premature Rats
An experimental study from the Guangdong Women and Children Hospital neonatal team testing Bifidobacterium adolescentis in a neonatal rat model of necrotizing enterocolitis. Probiotic treatment raised the 72-hour survival rate from 56.3% to 86.7%, reduced intestinal injury severity, and altered TLR4, TOLLIP and SIGIRR expression, supporting probiotic strategies to prevent necrotizing enterocolitis in preterm infants.
  • Affiliated Hospital

Where Dr. Chen Yunbin practices

Guangzhou

Guangdong Women and Children Hospital

Chinese name: 广东省妇幼保健院
Guangdong Maternal and Child Health Hospital, a Grade-A tertiary institution founded in 1944 and the province's maternal-child technical guidance center, operates four campuses with 1,255 licensed beds, 4 national key specialties (including neonatology and obstetrics) and 2668 qualified staff.
Since 1944
82 years of women & child care
1,255
Licensed beds
4
National key specialties
695
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Chen Yunbin?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Chen Yunbin.